Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial
Nutrition · 2024
DOI: 10.1016/j.nut.2024.112397 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrition, 2024. Verfasst von Giovanni Di Nardo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Sapienza University of Rome, NESMOS Department, Pediatric Unit, Sant'Andrea University Hospital, Rome, Italy. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Palmitic Acids, Amides, Ethanolamines. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
OBJECTIVE: This study aimed to evaluate the efficacy and safety of co-micronized palmitoylethanolamide (PEA)/polydatin (PD) in the treatment of abdominal pain symptoms in pediatric patients with irritable bowel syndrome (IBS). METHODS: This was a multicenter trial conducted at three Italian pediatric gastroenterology centers, employing a double-blind, placebo-controlled, parallel-arm design. Participants were ages 10 to 17 y and met Rome IV criteria for pediatric IBS. They were randomly allocated to receive either co-micronized PEA/PD or placebo, administered three times daily in a 1:1 ratio, over a 12-wk period. The study assessed baseline severity using the IBS-Severity Scoring System (IBS-SSS) at enrollment and after 4, 8, and 12 wk of treatment. Abdominal pain frequency was assessed on a scale from 1 to 7 d/wk, while stool consistency was classified using the Bristol Stool Scale (BSS) to categorize various IBS subtypes. The primary outcome was the percentage of patients who achieved complete remission, defined as IBS-SSS score
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sapienza University of Rome, NESMOS Department, Pediatric Unit, Sant'Andrea University Hospital, Rome, Italy.
- Pediatric Unit, Department of Childhood and Developmental Medicine, Fatebenefratelli-Sacco Hospital, Milan, Italy.
- Department of Medical and Surgical Sciences, University of Bologna and IRCCS Azienda Ospedaliero Universitaria di Bologna, Bologna, Italy.
- Pediatric and Pediatric Emergency Unit, "Umberto Bosio" Center for Digestive Diseases, The Children Hospital, AO SS Antonio e Biagio e C. Arrigo, Alessandria, Italy.
- Sapienza University of Rome, Department of Medical and Surgical Sciences and Biotechnologies, Polo Pontino, Latina, Italy; Unit of Anaesthesia, Intensive Care and Pain Medicine, Sant'Andrea University Hospital, Rome, It…
- Sapienza University of Rome, NESMOS Department, General Surgery Unit, Sant'Andrea University Hospital, Rome, Italy.
Zitieren
APA
Di Nardo, G., Bernardo, L., Cremon, C., Barbara, G., Felici, E., Evangelisti, M., Ferretti, A., Furio, S., Piccirillo, M., Coluzzi, F., Parisi, P., Mauro, A., Di Mari, C., D'Angelo, F., & Mennini, M. (2024). Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial. Nutrition. https://doi.org/10.1016/j.nut.2024.112397
Vancouver
Di Nardo G, Bernardo L, Cremon C, Barbara G, Felici E, Evangelisti M, et al. Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial. Nutrition. 2024. doi:10.1016/j.nut.2024.112397
BibTeX
@article{DiNardo2024,
author = {Di Nardo, Giovanni and Bernardo, Luca and Cremon, Cesare and Barbara, Giovanni and Felici, Enrico and Evangelisti, Melania and Ferretti, Alessandro and Furio, Silvia and Piccirillo, Marisa and Coluzzi, Flaminia and Parisi, Pasquale and Mauro, Angela and Di Mari, Clelia and D'Angelo, Francesco and Mennini, Maurizio},
title = {Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial},
journal = {Nutrition},
year = {2024},
doi = {10.1016/j.nut.2024.112397}
}
EUVIMED